Program Goals. The Role of Chemotherapy in Improving Quality of Life in Advanced NSCLC.

Slides:



Advertisements
Similar presentations
Medical Oncology Division, Terni
Advertisements

Advances and Emerging Therapy for Lung Cancer
O VARIAN C ANCER C LINICAL T RIALS P LANNING M EETING Unanswered Questions in Upfront Therapy IP Therapy Issue Keiichi Fujiwara, MD, PhD Saitama Medical.
Educational Objectives Metastatic Breast Cancer: Scope of the Problem.
NDA SE-011 Docetaxel FDA Review. FDA Review Team Biostatistics –Clara Chu, PhD. –Gang Chen, PhD. Biopharmaceutics –Safaa Ibrahim PhD –Atiq Rahman,
Belani CP et al. ASCO 2009; Abstract CRA8000. (Oral Presentation)
Multimodal Management of Opioid-Induced Constipation
Symptom Control and Enhancing Functioning in Schizophrenia
Introduction to Direct-to-Consumer Genetic Testing
The Nurse View: Management of Pancreatic Cancer
Evolving Paradigms in Recurrent/Metastatic SCCHN
The Nurse View.
Burden of Atrial Fibrillation The Percentage of Strokes Attributable to AF Increases With Age.
A New Path Forward: Immune Checkpoint Inhibitors in Bladder Cancer
Updated CINV Guidelines New Evidence for Change and Practical Issues
Primary Care Challenges in Depression - To Treat or Refer?
Figure 2 Underreporting by physicians of specific treatment-associated symptoms by physicians in the TORCH trial Figure 2 | Underreporting by physicians.
Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.
Advanced NSCLC Without Actionable Mutations
Assessing the Impact: New Data in T790+ NSCLC
The Changing Therapeutic Landscape of CINV
Emergency Management of NOAC Bleeding
The Comprehensive Major Depressive Disorder Care Team
REFLECT: First-Line Lenvatinib vs Sorafenib in HCC Study Design
New Standards of Care in ALK-Translocated Advanced NSCLC
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
Learning Objectives. A Multidisciplinary Approach in Advanced NSCLC in the Era of Immuno-Oncology.
Optimizing the Treatment of Recurrent/Metastatic SCCHN
Activity Goals. Perspectives on PARP Inhibitors in Ovarian Cancer Has the Time Come for Individualized Care?
Surveying the Safety of NOACs in the Real World
Emerging Data in Cancer Supportive Care
Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.
Chronic Idiopathic Urticaria
Managing CINV and Cachexia
The Evolving Role of Immunotherapy in NSCLC
Managing gBRCA-Positive Metastatic Breast Cancer
More Than Meets the Eye.
Advances in the Management of Severe and Life-Threatening Chemotoxicity.
EHL Technologies in Hemophilia Care
Essential Concepts in the Use of Immunotherapies in Bladder Cancer
Program Goals Overview Glatiramer Acetate 3 Times a Week.
Advancing Care in Genitourinary Cancer: Perspectives From Chicago
Advancing the Treatment of IBD With Biologics
Case 1: Introduction. Adjuvant Therapy: Should It Be Considered in Older Patients With NSCLC?
Advancing Care Across the Spectrum of Pancreatic Cancer
Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
Immune Checkpoint Inhibitors in Lung Cancer
Locally Advanced Lung Cancer
Scientific Update.
Treatment of Locally Advanced Pancreatic Cancer
Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.
The Burden of Psoriasis:
Management of Advanced Pancreatic Adenocarcinoma
Patient-Centered Management in Advanced Non-Small Cell Lung Cancer
Practical Guidance on the Management of Pan-Negative NSCLC
Application of Biologics in IBD:
Challenges in LA SCCHN.
Emerging Regimens in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Preparing for Checkpoint Inhibitors in Breast Cancer
This program will include a discussion of off-label treatment and investigational agents not approved by the Food and Drug Administration for use in the.
A Multidisciplinary Perspective on the Management of Hypoparathyroidism.
Quality Improvement and Molecular Profiling in Advanced Non-Small Cell Lung Cancer.
Case Studies in Locally Advanced Pancreatic Cancer
Taking a Closer Look at Recurrent/Metastatic SCCHN
Going Beyond EXTREME in Head and Neck Cancer
Physiologic vs Chronologic Age
Physiologic vs Chronologic Age
Rethinking Risk Stratification for Nonischemic HF:
The Nurse View: Practice Pearls in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC.
Presentation transcript:

The Role of Chemotherapy in Improving Quality of Life in Advanced NSCLC

Program Goals

Introduction

Assessing Health-Related QoL in Advanced NSCLC

Chemotherapy + Supportive Care vs Supportive Care Alone in Advanced NSCLC

Symptom Control / Relief Impact on QoL in Advanced NSCLC

Individualized Chemotherapy Selection

Cisplatin vs Carboplatin

Effective Management of Chemotherapy-induced Nausea and Vomiting Associated With Platinum Agents

Individualizing Chemotherapy Selection PointBreak Trial: Safety Results

Nab-paclitaxel vs Solvent-based Paclitaxel in First-line Chemotherapy Trial Design

Nab-paclitaxel vs Solvent-based Paclitaxel in First-line Chemotherapy Efficacy Results

Nab-paclitaxel vs Solvent-based Paclitaxel in First-line Chemotherapy Safety Results

Impact of Palliative Care in Advanced NSCLC

Depression in Advanced NSCLC

Other Interventions

Other Interventions (cont)

Summary

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.